Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
Sab Biotherapeutics, Inc.
Filing: 10-Q
Filed On: 2023-05-15
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
10-Q
10-Q
EX-4.1
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
EX-31.1
Management Certification of annual or quarter disclosure
EX-31.2
Management Certification of annual or quarter disclosure
EX-32.1
Section 1350 Certifications
EX-32.2
ex_505507.htm
0001437749-23-014634.txt
Data files
EX-101.SCH
sabs-20230331.xsd
EX-101.CAL
sabs-20230331_cal.xml
EX-101.DEF
sabs-20230331_def.xml
EX-101.LAB
sabs-20230331_lab.xml
EX-101.PRE
sabs-20230331_pre.xml
XML
sabs20230331_10q_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.